Tags: Drug.
CSP-2503 is a potent and selective 5-HT1A receptor agonist 5-HT2A receptor antagonist and 5-HT3 receptor antagonist of the phenylpiperazine class. First synthesized in 2003 it was designed based on computational models and QSAR studies. In rat studies CSP-2503 has demonstrated anxiolytic effects and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.
